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Summary
Objective: In the current studies we have examined the effects of nitric oxide, and its redox derivatives peroxynitrite and S-nitrosothiol,
S-nitrosocysteine, on nuclear factor kappaB (NF-kB) activation in cytokine-stimulated bovine chondrocytes.
Methods: The kinetics of NF-kB activation ( p65 nuclear translocation) were assessed by immunoﬂuorescence and immunoblot assays.
Results: We observed that the two nitric oxide redox species, peroxynitrite and S-nitrosocysteine, exert opposing effects on NF-kB activation.
However, in lipopolysaccharide (LPS)/cytokine-stimulated chondrocytes (LPS, IL-1b and TNF-a (LIT)) in the presence or absence of the NOS
inhibitor L-NG-monomethyl arginine citrate (L-NMMA), the results indicate that nitric oxide causes persistent activation of NF-kB, most likely via
generation of the free radical derivative peroxynitrite.
Conclusion: The studies indicate that while nitric oxide is not required for immediate NF-kB activation in cytokine-stimulated chondrocytes, its
effect is to sustain nuclear translocation of p65 and thereby provide a persistent ‘‘on signal’’ to NF-kB dependent gene transcription. Persistent
activation of NF-kB may represent a mechanism by which nitric oxide sustains catabolic processes and promotes cartilage degeneration in
osteoarthritis.
 2004 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Introduction
Nitric oxide is spontaneously produced by chondrocytes in
osteoarthritis, where in concert with a variety of proteolytic
enzymes, cytokines and growth factors, it contributes to
progressive cartilage degradation. The intracellular signal-
ing mechanisms by which nitric oxide promotes the cata-
bolic phenotype of chondrocytes are not fully characterized.
Since nitric oxide is known to exert effects on nuclear factor
kappaB (NF-kB) signaling in other cells types, we undertook
studies that examined its regulation of NF-kB in bovine
chondrocytes. NF-kappaB is a transcription factor that is
rapidly activated in response to inﬂammatory stimuli, such
as IL-1b and TNF-a. NF-kB dependent genes in chondro-
cytes include key products that promote cartilage degrada-
tion, including IL-1b and TNF-a, the inducible nitric oxide
synthase (iNOS), metalloproteinases such as MMP-13,
chemokines and cyclooxygenase-2 (COX-2)1,2.
In resting cells NF-kB is maintained in an inactive state,
held in the cytoplasm as a stable trimeric complex of two
NF-kB subunits ( p65, p50) and IkappaB alpha (IkappaB).
IkappaB prevents nuclear translocation and DNA binding
of NF-kB by masking its nuclear localization signal. In re-
sponse to proinﬂammatory stimuli, IkappaB is phosphory-
lated, which results in its ubiquitination and rapid
degradation by the proteasome protease complex. Trans-
location of the NF-kB subunits to the nucleus ensues, and
transcription is initiated when the p65/p50 dimer engages
speciﬁc DNA binding sites in the promoter regions of
responsive genes.
The promoter region of the iNOS gene contains an NF-kB
binding site, which contributes to the regulation of nitric
oxide production. Deletion of the NF-kB sites from this
promoter prevents cytokine-induced increases in iNOS
transcription3. Nitric oxide regulates NF-kB activation,
having been reported to either stimulate or inhibit activity
depending on the cell-type. In human neutrophils, nitric
oxide activates via the NF-kB production of peroxynitrite4.
Conversely, nitric oxide has been shown to inhibit NF-kB
activation in human respiratory cells and murine macro-
phages by S-nitrosylation of a critical thiol in the DNA-
interacting p50 subunit5. Nitric oxide has also been reported
to enhance IkappaB production in murine macrophages,
which results in sustained inhibition of NF-kB6. These
results show that nitric oxide modulates NF-kB function, but
whether it activates or inhibits, varies with the cell-type and
experimental conditions. It is probable that the apparent
paradoxical effects of nitric oxideonNF-kBactivation in these
reports reﬂect the activity of different redox end-products of
nitric oxide generated in each experimental system7.
In the current studies we have examined the effects of
nitric oxide, and its redox derivatives peroxynitrite and
S-nitrosothiol, S-nitrosocysteine, on NF-kB activation in
cytokine-stimulated bovine chondrocytes. The kinetics of
NF-kB activation ( p65 nuclear translocation) were as-
sessed by immunoﬂuorescence and immunoblot assays.
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peroxynitrite and S-nitrosocysteine, exert opposing effects
on NF-kB activation. However, in cytokine-stimulated
chondrocytes, induced nitric oxide causes persistent
activation of NF-kB, most likely via generation of the free
radical derivative peroxynitrite.
Methods
CULTURE OF BOVINE CHONDROCYTES
Bovine articular chondrocytes were obtained from the
bovine fetlock joint as described8. Brieﬂy, slices of articular
cartilage underwent digestion to isolate chondrocytes (hya-
luronidase, trypsin, and collagenase). Cells were cultured in
monolayer in DME plus 10% FBS. Monolayer cultures of
passage one bovine articular chondrocytes were grown with
medium alone (DME+0.2% FBS) or with a cytokine mix-
ture containing 5 ng/ml human IL-1b, 10 ng/ml TNF and
LPS (0.1 mg/ml) in the absence or presence of 1.0 mM
L-NG-monomethyl arginine citrate (L-NMMA). Authentic
peroxynitrite was commercially obtained (Cayman) and
S-nitrosocysteine ethyl ester (SNCEE) was prepared as pre-
viously described9. Cell death was monitored by measuring
release of lactate dehydrogenase (LDH) using a kit and
following the recommendation of the manufacturer (Sigma).
ANALYSIS OF NITRIC OXIDE AND S-NITROSOTHIOLS
Nitric oxide release was measured as nitrite in supernate
at 24 h by using the Griess assay. Intracellular SNO thiols
were measured by a ﬂuorescent assay employing 2,3-
diaminonaphthalene (0.5 mM) and HgCl2 (0.4 mM) as
previously described10.
NF-kB LOCALIZATION BY IMMUNOFLUORESCENCE
Chondrocytes on glass coverslips were incubated with or
without lipopolysaccharide (LPS), IL-1b and TNF-a (LIT) in
DMEM culture medium+0.2% FCS at 37(C and at the
indicated times ﬁxed with 4% paraformaldehyde (10 min),
washed in phosphate buffered saline (PBS) (3!, 5 min);
permeabilized with acetone (1 min), washed in PBS (3!,
5 min); and blocked with 1% normal goat serum (NGS) in
PBS for 1e2 h at room temperature. Cells were incu-
bated with Hoechst 33258 (Molecular Probes, binds DNA
0.01 mg/ml). Polyclonal antibody to p65 (catalog number
sc-372, Santa Cruz Biotechnology, Santa Cruz, CA) was
diluted 1:100 in NGS and applied at RT (1 h), followed by
washing in PBS and incubation for 2 h at room temperature
with FITC goat anti-mouse IgG (Vector Laboratories Inc.,
Burlingame, CA) diluted 1:200 in NGS. Coverslips were
washed, mounted on slides with Vecta-Shield (Vector La-
boratories Inc.), and examined using a Zeiss LSM 510
laser-scanning confocal microscope. To quantitatively eval-
uate NF-kB activation, we selected a method11 which is
based on the localization of ﬂuorescent label in all chon-
drocytes on each coverslip (usually 40e70 cells/coverslip).
Chondrocytes were rated positive for nuclear localization if
ﬂuorescence intensity of one or more nuclei exceeded that
of the cytoplasm.
NF-kB AND IKAPPAB LOCALIZATION BY IMMUNOBLOT
Nuclear and cytoplasmic extracts were prepared using
NE-PER Nuclear and Cytoplasmic Extraction Reagents(Pierce, catalog number 78833) according to the manufac-
turer’s instructions. The protein content was determined
with a Micro-BCA Protein assay (Pierce). An equal amount
of protein (10 mg) was loaded onto 10% SDS-polyacryl-
amide gels. Proteins were separated at 120 V for 1.5 h and
then blotted to nitrocellulose membranes (0.2 mm) in trans-
fer buffer (25 mmol/l Tris, 192 mmol/L-glycine, 20% meth-
anol [vol/vol]) at 18 V overnight at 4(C. The blots were
blocked with 5% nonfat dry milk in PBS and 0.1% Tween-20
(PBST) at room temperature for 1 h. Membranes were
incubated with antibodies recognizing p65 (1:3000) or
IkappaB alpha (1:1000, Santa Cruz Biotechnology). Mem-
branes were washed with PBST six times for 30 min and
incubated with anti-rabbit peroxidase-conjugated secondary
antibodies for 1 h. Blots were washed and developed using
the ECL chemiluminescence detection reagent (Pierce).
Immunoblot of NF-kB was quantitatively analyzed after
scanning the image and quantitating pixels using the Im-
ageQuant program.
SEMI-QUANTITATIVE RT-PCR
Total RNA was isolated from the cells by homogenizing
the cell pellets in TRIzol (Invitrogen, catalog number 15596-
026) reagent for 1 min. RNA was extracted by chloroform
treatment and propanol precipitation. Total RNA (5 mg) was
reverse transcribed from an oligo(dT) primer in a 20 ml ﬁnal
reaction volume using Superscript transcriptase (Invitrogen,
catalog number 18064-014) according to the manufactur-
er’s recommendations. For PCR reactions, 2 ml of the cDNA
from each RT reaction was ampliﬁed with the gene speciﬁc
primers in 50 ml volume containing 5% formamide and Vent
polymerase (New England Biolabs, catalog number
M0254S). The PCR reactions were subjected to 20, 25, 30
and 35 cycleswith denaturation at 98(C for 40 s, reannealing
at 50(C for 1 min, extension of 67(C for 1 min. The PCR
products were analyzed by electrophoresis through a 1%
agarose gel stained with ethidium bromide. iNOS, GAPDH
andRel A ( p65) were ampliﬁed byRT-PCRusing the speciﬁc
primers designed from the published sequences as p65
forward 5#-GCTGCATCCACAGTTTCC-3# and reverse 5#-
GTCCGGAACACAATGGCCAC-3#, GAPDH forward 5#-AT-
CACTGCCACCCAGAAGAC-3# and reverse 5#-ATGAGGT-
CCACCACCCTGTT-3# and iNOS forward 5#-GTTCGAAT-
CTCCCTGGTC-3# and reverse 5#-CTGTCACCTGGAAGCA-
GA-3#, respectively.
STATISTICAL ANALYSIS
Data were analyzed using the Student’s t test to determine
statistical signiﬁcance between groups (P!0:05).
Results
EFFECTS OF EXOGENOUS PEROXYNITRITE AND THE S-NITRO-
SOTHIOL, SNCEE, ON NF-kB ACTIVATION IN CHONDROCYTES
We compared the capacity of exogenous nitric oxide,
delivered as SNCEE or as the free radical derivative,
peroxynitrite, to affect activation of NF-kappaB by analyzing
changes in the immunoﬂuorescent nuclear localization of
the p65 subunit. Treatment with IL-1b (5 ng/ml, 6 h, 37(C)
resulted in increased ﬂuorescence intensity of the nucleus,
exceeding that of the cytoplasm, in four of 10 cells (40%
positive; Fig. 1). IL-1b stimulated chondrocytes were next
evaluated in the presence or absence of peroxynitrite
554 R. M. Clancy et al.: NO and persistent activation of NF-kappaBFig. 1. Effects of peroxynitrite and SNCEE on IL-1b stimulated NF-kB ( p65) nuclear translocation (immunoﬂuorescent assay). Chondrocytes
were cultured with or without IL-1b (6 h) in the presence or absence of pretreatment (30 min) with peroxynitrite (PN, 100 mM) or
S-nitrosocysteine ethyl ester (SNCEE, 10 mM). Cells were stained with FITC labeled anti-p65 (Rel A). The percentage of chondrocytes in
which p65 was predominantly detected in the nucleus ( ﬂuorescence intensity of the nucleus exceeded that of the cytoplasm) was determined.
Peroxynitrite enhanced, while SNCEE attenuated, IL-1b induced nuclear translocation of p65. This experiment was performed three times.(0.1 mM) or nitric oxide (10 mM), delivered as SNCEE.
Pretreatment with peroxynitrite increased the percent of
chondrocytes with positive p65 nuclear staining from 40% to
73%. In contrast, treatment of IL-1b stimulated chondro-
cytes with SNCEE reduced the percentage of p65 positive
chondrocytes from 40% to 5%. The concentrations of
peroxynitrite and SNCEE were selected at levels which did
not cause cell death as assessed by measuring the release
of LDH assay.
ENDOGENOUS NITRIC OXIDE PROMOTES THE PERSISTENT
ACTIVATION OF NF-kB STIMULATED CHONDROCYTES
The above studies indicated that two distinct redox forms
of nitric oxide, peroxynitrite and SNCEE, exerted opposing
effects on NF-kappaB activation. We have previously re-
ported that the exposure of cultured bovine chondrocytes to
IL-1b results in a marked increase in intracellular peroxyni-
trite and superoxide anion generation12. Therefore, we
performed studies to examine the effects of endogenous
cytokine-induced nitric oxide on NF-kB activation and to
determine whether these were more consistent with per-
oxynitrite than S-nitrosothiol production. Chondrocytes were
incubated with and without LIT in the presence or absence
of L-N-monomethyl arginine (L-NMMA, 1.0 mM). This mix-
ture of LPS and cytokines was utilized to ensure maximal
induction of iNOS and nitric oxide generation, which is
suboptimal using the individual stimuli alone8. Nitric oxide
production by LIT-stimulated chondrocytes was reduced by
over 90% in the presence of L-NMMA.
IMMUNOFLUORESCENCE STUDIES
In these experiments we performed double staining,
using Hoechst reagent to identify nuclei and the immuno-
ﬂuorescent technique to localize the p65 subunit of NF-kB.
In control cells, low levels of nuclear NF-kB immunostaining
were detected with the majority of nuclei staining blue
(Hoechst 33258); the cytosol stained green, consistent with
the immunodetection of p65 (Fig. 2, panel A). Following
exposure to LIT, nuclear levels of p65 increased markedly;
nuclear translocation was maximal at 1 h (panel B) and
sustained at 6 h (panel C). LIT was a more potent stimulus
to p65 nuclear translocation than IL-1b, and resulted in
100% of the nuclei staining positive, compared to 40% withFig. 2. Effects of L-NMMA on LPS, IL-1b and TNF-a (LIT)-induced
nuclear translocation of p65. Chondrocytes were cultured with or
without LIT (5 ng/ml human IL-1b, 10 ng/ml TNF-a and LPS (0.1 mg/
ml), time varied) in the absence or presence of L-NMMA (1.0 mM).
NF-kappaB activity was assessed using an immunoﬂuorescent
method, in which cells were double stained with Hoechst 33258
and FITC labeled anti-p65. Cells were incubated in the absence
(panel A) or presence of LIT for 1 h (panel B, minus NMMA; panel
D, plus NMMA) and for 6 h (panel C, minus L-NMMA; panel E, plus
L-NMMA). Note that nuclear localization of NF-kB is evident in LIT
(panel C) but not in LIT+NMMA (panel E), which suggests that
endogenous nitric oxide contributes to sustained NF-kappaB
translocation. This experiment was performed three times.
555Osteoarthritis and Cartilage Vol. 12, No. 7IL-1b alone. The addition of L-NMMA (at concentrations
sufﬁcient to inhibit nitric oxide by greater than 90%), had no
effect at 1 h (panel D) but reduced p65 nuclear accumula-
tion at 6 h (panel E).
IMMUNOBLOT STUDIES
In order to conﬁrm and better quantify the immunoﬂuo-
rescent studies we next performed subcellular fractionation
followed by immunoblot of nuclear fractions (Figs. 3 and 4).
Immunoblot assessment of the kinetics of NF-kB activation
conﬁrmed the immunoﬂuorescence ﬁndings: compared with
baseline p65, which was detected in the nuclear fractions of
Fig. 3. Exposure of chondrocytes to LPS, IL-1b and TNF-a with or
without L-NMMA and assessments of stimulated NF-kB nuclear
translocation by immunoblot assay.Chondrocyteswere culturedwith
or without LIT (5 ng/ml human IL-1b, 10 ng/ml TNF and LPS (0.1 mg/
ml), time varied) in the absence or presence of L-NMMA (1.0 mM,
L-NG-monomethyl arginine citrate). Nuclear (NE) and cytoplasmic
extracts (CY) were prepared and NF-kB activity was assessed by
Western blot. This experiment was performed three times.unstimulated chondrocytes, there was an increase in the
nuclear p65 reported in LIT-treated chondrocytes, which
was maximal at 1 h and sustained at 6 h (Fig. 3). We next
evaluated the contribution of endogenous nitric oxide to the
kinetics of NF-kB activation. Pretreatment of chondrocytes
with L-NMMA markedly reduced LIT-induced nuclear trans-
location of p65 at 6 h (Figs. 3 and 4). Importantly, in LIT-
treated chondrocytes, there was a transient decrease in
cytosolic p65, which recovered to levels above those
observed in resting chondrocytes. In LIT +NMMA treated
chondrocytes, we observed an initial decrease in cytosolic
p65 as expected, but the levels of cytosolic p65 remained
below those reported by resting chondrocytes. Using a
quantitation of the Western blot result (pixel quantitation,
ImageQuant), we observed that following exposure to LIT,
nuclear p65 was detectable at 5 min, the levels reached
a plateau at 15 min and it remained at sustained high levels
at 6 h (Fig. 4). In contrast, in LIT+NMMA group, there was
a signiﬁcant attenuation of nuclear levels of p65 at 6 h
(213+31 vs 81+14, P ¼ 0:05).
THE EXPRESSION OF INOS BY LIT-TREATED CHONDROCYTES IS
UNAFFECTED BY L-NMMA
Since L-NMMA did not affect p65 translocation at the
early time points, we examined the kinetics of iNOS and
NF-kB (p65) mRNA expression. Chondrocytes were treated
with IL-1b or IL-1b plus L-NMMA and RNA isolated for semi-
quantitative RT-PCR analysis. iNOS mRNA was not
detected in unstimulated chondrocytes, but did appear by
the third hour following LIT treatment, as expected (Fig. 5).
L-NMMA had no effect on iNOS expression (Fig. 5). In
contrast, p65 was detected in resting cells, and its levels
were not affected by either IL-1b or L-NMMA.
L-NMMA ADDED AT 3 H ATTENUATED P65 NUCLEAR
ACCUMULATION
To determine whether the inhibition of NF-kB activation
by L-NMMA required pretreatment of chondrocytes, weFig. 4. Quantitative measurements of resting and stimulated NF-kB levels which were reported in Western blots of nuclear and cytosolic
fractions for chondrocytes in the absence and presence of LPS, IL-1b and TNF-a with or without L-NMMA. Levels of nuclear NF-kB and
cytosolic NF-kB were reported after scanning the image (from the immunoblot, Fig. 3) and quantitating pixels using the ImageQuant program.
The nuclear expression of Rel A in control cells represents 100% on the Y-axis (indicated as horizontal solid line). This experiment was
performed three times.
556 R. M. Clancy et al.: NO and persistent activation of NF-kappaBFig. 5. Exposure of chondrocytes to LIT with and without L-NMMA and effect of L-NMMA on LIT-stimulated expression of iNOS, NF-kappaB
(p65) and GAPDH. Chondrocytes were cultured as passage one cells with or without 5 ng/ml human IL-1b, 10 ng/ml TNF and LPS (0.1 mg/ml)
for 15 min, 6 h in the absence and presence of L-NMMA (1 mM). RNA was isolated from cells and iNOS and RelA expressions were
determined by RT-PCR (GAPDH as RNA control). This experiment was performed two times.performed experiments in which the NOS inhibitor was
added after p65 translocation had already been initiated
and achieved maximal levels. As shown in Fig. 6, L-NMMA
added at 3 h after exposure to LIT attenuated persistent
nuclear accumulation of p65 at 6 h. These results indicate
that while nitric oxide production is not required for the
immediate translocation of p65, its production following
cytokine stimulation results in the continuing and sustained
activation of NF-kB. Moreover, the lack of effects of
L-NMMA at the early time points reﬂects the absence of
iNOS in cultured chondrocytes until 3 h post-LIT stimulation.
EFFECTS OF NITRIC OXIDE ON CYTOSOLIC IkB
We next performed studies to determine whether the
capacity of nitric oxide to sustain the nuclear accumulation
of p65 was associated with changes in cytosolic levels of
Fig. 6. Exposure of chondrocytes to LIT+NMMA where L-NMMA is
added at 3 h post-stimulation and assessments of stimulated NF-
kB nuclear translocation by immunoblot assays. Chondrocytes
were cultured as passage one cells with or without LIT (5 ng/ml
human IL-1b, 10 ng/ml TNF and LPS (0.1 mg/ml), time varied). After
a 3 h interval with LIT, L-NMMA (1 mM) was added. NF-kB activity
was assessed using the immunoblot method (Fig. 3). Rel A was
stained using the Western blot technique and quantitated using the
ImageQuant program. The nuclear expression of Rel A in control
cells represents 100% on the Y-axis. This experiment was
performed once.IkappaB. IkappaB immunoblots were performed on cyto-
solic fractions of LIT-treated cells in the presence or
absence of L-NMMA. As shown in Fig. 7, IkappaB rapidly
disappeared from the cytosol following treatment with LIT,
as expected. In control cells, replenishment of cytosolic
IkappaB levels was apparent by 1 h, and levels continued to
increase by 6 h. In contrast, in the presence of L-NMMA,
IkappaB levels remained low following LIT at 1 h, and
although they increased by 6 h the levels of IkappaB in the
IL-1b plus L-NMMA group were lower than those in LIT
alone, suggesting that nitric oxide production promotes the
replenishment of cytosolic IkappaB. This observation
makes it unlikely that the capacity of nitric oxide to sustain
nuclear accumulation of p65 is due to effects on IkappaB.
Discussion
These studies demonstrate that nitric oxide and its de-
rivatives can regulate cytokine-induced NF-kB activation in
chondrocytes. The S-nitrosothiol SNCEE prevented NF-kB
nuclear translocation, possibly via the S-nitrosylation of
the p50 subunit, as suggested by Stamler and colleagues5.
In contrast, peroxynitrite, a proinﬂammatory redox deriva-
tive of nitric oxide, and a product of stimulated chon-
drocytes12, enhanced cytokine-induced NF-kB activation.
This dual effect of nitric oxide on NF-kB, mediated by dif-
ferent redox end-products, is consistent with prior reports
on neutrophils (peroxynitrite activates)13 and murine macro-
phages (S-nitrosothiols inhibit)5.
What then, is the effect of nitric oxide production on
chondrocytes? Our studies indicate that when chondrocytes
are exposed to a mixture of potent inﬂammatory stimuli, LIT,
the effect of induced nitric oxide is to sustain the activation
of NF-kB, as reported by the persistence of the p65/p50
subunits in the nucleus. These results are consistent with
the production of peroxynitrite as the predominant nitric
oxide-derived redox form in LIT-activated chondrocytes.
Indeed, we have previously shown that peroxynitrite, and
oxidants such as superoxide anion required for its
557Osteoarthritis and Cartilage Vol. 12, No. 7Fig. 7. Exposure of chondrocytes to a mixture of LPS, IL-1b and TNF-a with or without L-NMMA and assessments of IkappaB by immunoblot
assay. Chondrocytes were cultured with or without LIT (5 ng/ml human IL-1b, 10 ng/ml TNF and LPS (0.1 mg/ml), time varied) in the absence
or presence of L-NMMA (1.0 mM, L-NG-monomethyl arginine citrate). Cytoplasmic extracts were prepared and levels of IkappaB were
assessed by Western blot. In upper panel (LIT) and lower panel (LIT+NMMA), each lane of the Western is identiﬁed, above gel, by the time
interval of treatment. This experiment was performed once.production, are actively produced by cytokine-treated
chondrocytes and detected in experimental arthritis12,14,15.
However, it should be noted that our results do not exclude
the possibility that under less inﬂammatory conditions, the
intracellular redox potential could favor S-nitrosothiol pro-
duction by chondrocytes and result in inhibitory effects of
nitric oxide production on NF-kB activation.
The results of our studies are consistent with recent
in vivo and in vitro studies suggesting that peroxynitrite
promotes, and S-nitrosothiols inhibit, NF-kB signaling. Lush
and colleagues utilized iNOS/ and SOD transgenic mice
to evaluate the role of peroxynitrite formation, nitric oxide
and superoxide anion. In their studies, LPS-induced NF-kB
activation in ﬁbroblasts derived from each of these ge-
netically altered mice was signiﬁcantly reduced compared
to those isolated from wild type mice24. In LPS-stimulated
human leukocytes, peroxynitrite-induced IL-8 gene expres-
sion was blocked by the NF-kB inhibitor PDTC4. Finally, in
cultured endothelial cells, the peroxynitrite donor SIN-1
activated NF-kappaB, which resulted in the upregulation of
iNOS16.
Our data extend these ﬁndings by demonstrating that
nitric oxide, most probably via peroxynitrite, sustains NF-
kappaB signaling in activated chondrocytes, an event which
would be expected to further promote and amplify the
transcription of inﬂammatory cytokines, growth factors and
metalloproteinases. While most studies of NF-kappaB
activation have examined the rapid translocation of p65/
p50 subunits that follows IkappaB phosphorylation, little is
known about the factors that regulate persistent activation,
as may occur in the continued presence of inﬂammatory
stimuli. Our studies show that the persistent activation of
NF-kB is under the regulation of nitric oxide production, and
that the addition of NOS inhibitors is sufﬁcient alone to
interrupt this ongoing, dynamic process (Fig. 5).
The mechanism by which peroxynitrite activates NF-kB is
unknown. Previous studies have implicated the MAP kinase
ERK in the persistent activation of NF-kB. For example,
coactivation of ERK and NF-kB by IL-1 in articular
chondrocytes leads to MMP gene expression and inhibition
of IL-1 stimulated MAP kinases, activating protein-1 (AP-1
and NF-kB) transcription factors downregulates matrix
metalloproteinases gene expression17. Recently, sustained
activation of NF-kB via ERK activation has been observed
in human atherosclerotic lesions and in vascular smooth
muscle cells following arterial injury18,19. Several in vitro
models have utilized rat vascular smooth muscle cells toevaluate the effect of ERK on NF-kB activation. In these
studies, transfectionwithERKantisense,butnotsense,phos-
phorothioate-modiﬁed oligodeoxynucleotides decreased the
protracted activation of NF-kB induced by IL-1b18. Further-
more, IL-1b stimulates smoothmuscle cells to express ICAM-
1 and other gene products, which are dependent on NF-kB
pathway via a mechanism requiring the activation of ERK19.
Although oxidants have been shown to activate the ERK
pathway in chondrocytes, exogenous peroxynitrite has not
had a similar effect. However, nitric oxide may directly
stimulate one component of the ERK pathway as was
reported by Lander and coworkers20 in T cells. In those
experiments nitric oxide activated p21ras, resulting in ERK
activation. Alternatively, nitric oxide may inﬂuence ERK by
countering an inhibitory inﬂuence of PGE221. Recent data
from our laboratory, which have demonstrated that nitric
oxide suppresses prostaglandin E production by stimulated
chondrocytes, support this possibility22. This may be due to
the capacity of peroxynitrate to promote the nitration of
COX-2, which inhibits its catalytic activity23.
In summary, these data underscore the concept that nitric
oxide and its derivatives can exert contrasting effects on
inﬂammatory processes, depending upon the predominant
redox form produced in a target tissue. The evidence in-
dicates that in cytokine-activated chondrocytes nitric oxide
exerts proinﬂammatory and catabolic effects that may be
mediated in part by peroxynitrite production12,14. Our data
add to the understanding of these catabolic effects by
illustrating that induced nitric oxide promotes, and is
required for, the persistent activation of NF-kB following
exposure to IL-1b and TNF-a. The results suggest that nitric
oxide, via peroxynitrite, acts as an intracellular ‘‘on signal’’
that sustains the actions of catabolic cytokines. Further
advances in understanding the mechanisms of NF-kB ac-
tivation by mediators produced in osteoarthritis will provide
insights into the regulation of catabolic pathways that
promote cartilage degeneration.
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